698 Results
Filter
Sort
Sort by Recently Updated
Filter
Categories
- 500 Cities & Places
- Alcohol-Related Disease Impact
- Assisted Reproductive Technology (ART)
- Behavioral Risk Factors
- Chronic Disease Indicators
- Healthy Aging
- Heart Disease & Stroke Prevention
- Maternal & Child Health
- Nutrition, Physical Activity, and Obesity
- Oral Health
- Tobacco Use Show all options for %{facet_category}
- Vision & Eye Health
- Youth Risk Behaviors
Tags
- activity
- adolescents
- adult cigarette use
- allocation
- american community survey
- appropriation
- appropriations
- astdd
- average cost per pack
- awards
- barriers to treatment
- bars
- basic screening survey
- bike
- binge
- body mass index (bmi)
- breastfed
- bss
- built environment
- caries
- caries experience
- casinos
- cataract
- census tracts
- chd
- checkup
- cigar use
- cigarette excise tax
- colorectal
- comprehensive smokefree indoor air
- consumption
- copd
- coronary
- counseling
- current asthma
- dental
- dental sealants
- department of health and human services
- dollars
- drinking
- expenditure
- expenditures
- farm
- federal
- fee-for-service plan
- fire safety
- funds
- gaming
- gats
- ghpss
- glaucoma
- grants
- gross cigarette tax revenue per state
- group counseling
- gsps
- gyts
- health communication
- healthy people 2020
- homes
- hospitalizations
- housing
- individual counseling
- infants
- insurance
- interventions
- kidney
- leading health indicator
- low income
- mammogram
- mammography
- marketscan
- max
- medicaid barriers to treatment
- medicare
- medication
- mental
- methods
- money
- multiunit housing
- myocardial infarction
- national immunization survey
- nhanes
- nhis
- nis
- nyts
- obese
- pap
- papanicolaou
- physical activity education
- qit
- quit attempt
- recommendation
- recommended level
- restaurants
- rules
- school personnel
- sleep
- smokeless tobacco products
- soda
- spending
- state and community
- students
- survey questions
- tobacco settlement payments
- tooth decay
- transportation
- treated prevalence
- truven
- tv
- untreated tooth decay
- vegetable
- vision correction
- vision exam measures
- visual acuity
- vsp
- walk
- walking
- wic-pc
- work
- worksites
- youth cigarette use
- youth tobacco sales
- zoning
- acs
- age-adjusted
- any tobacco
- blindness
- boundaries
- centers for disease control and prevention
- child
- children
- cigarette sales
- claims data
- combustibles
- comprehensive medicaid coverage
- comprehensive medicaid coverage of cessation treatment
- diagnosed prevalence
- frequent
- hookah
- loose tobacco
- mmsa
- national
- non-combustibles
- nsch
- physical
- pipe tobacco
- products
- questions
- risk factors
- roll-your-own tobacco
- sae
- sam
- shapefile
- smokefree campus
- system
- tax burden on tobacco
- tobacco consumption
- tobacco products
- total recommended program costs
- user
- vegetables
- vision
- visual
- aging
- caregiver
- cdc
- cognitive health
- diseases of the heart
- ecigarette
- every day
- eye exams
- falls
- former
- frequency
- fruit
- funding
- managed care plan
- mortality
- never
- oshdata
- overall health
- overweight
- per capita
- pipe
- screening
- screenings
- some days
- vaccines
- youth access
- yrbss
- art
- assisted reproductive technology
- best practices
- blind
- claims
- clinic
- dentist
- ever
- fertility
- fruits and vegetables
- gshs
- gtss
- healthy people
- infertility
- medical diagnoses
- nutrition
- sammec
- secondhand smoke
- slides
- smart
- student health
- success rates
- water fluoridation
- wfrs
- best practices for comprehensive tobacco control programs
- cessation intervention
- cigar
- contact lenses
- dental care
- glasses
- global
- health communication interventions
- licensure
- smokefree
- state and community interventions
- youth
- access to care
- administration and management
- age
- american lung association
- blood pressure
- callers
- cardiovascular health
- cleft lip/cleft palate recording
- cleft lip/cleft palate referral to care
- cvd risk factors
- demographics
- dental cleaning
- dental visits
- dnpao
- education
- ethnicity
- faq
- gender
- infographic
- infrastructure
- intervention
- medicaid coverage of cessation treatment
- national quitline data warehouse
- nqdw
- place
- programs
- quit-now
- race
- school based sealant programs
- service utilization
- sodium
- state dental directors
- state oral health program characteristics
- surveillance and evaluation
- tooth loss
- tract
- visual function
- workforce
- zcta
- zip code
- adults
- census tract
- cessation coverage
- cigarette use
- coronary heart disease
- heart
- middle school
- sexual contacts
- sexual identity
- sexual orientation
- smokeless
- smoking status
- cerebrovascular disease
- cholesterol
- city
- preemption
- quitline
- smokefree indoor air
- tax
- counties
- current
- high school
- interactive map
- smoker
- division of oral health
- eye diseases
- heart diseases
- nohss
- state
- vhi
- 500cities
- cigarette
- cities
- quit
- adult
- cardiovascular
- cessation
- fact sheet
- heart disease
- services
- vision impairment
- yrbs
- e-cigarette
- physical activity
- surveillance
- methodology
- risk behavior
- youth online
- glossary
- health
- hypertension
- status
- asthma
- cdi
- chronic disease indicators
- chronic kidney disease
- chronic obstructive pulmonary disease
- disability
- gis
- immunization
- nutrition physical activity and weight status
- older adults
- overarching conditions
- public health
- arthritis
- unhealthy
- abuse
- alcohol use
- cancer
- contraception
- infant health
- morbidity
- preconception health
- pregnancy history
- prenatal care
- sleep behavior
- smoke exposure
- smoking
- stress
- unintended pregnancy
- medicaid
- wic
- breastfeeding
- county
- places
- stroke
- ...
- obesity
- diabetes
- estimates
- factor
- tobacco use
- legislation
- 500 cities
- oral health
- tracts
- behaviors
- office on smoking and health
- outcomes
- prevention
- behavioral
- mental health
- policy
- reproductive health
- census
- cardiovascular disease
- risk
- state system
- survey
- brfss
- tobacco
- prevalence
- osh
- aad
- aaf
- alcohol-related disease impact
- ypll
- alcohol
698 Results
1999-2023. National Association of Attorneys General (NAAG). Policy—Tobacco Settlement Payments. The National Association of Attorneys General (NAAG) provides Tobacco Settlement Revenue data for 46 states participating in the Master Settlement Agreement (MSA) with the four largest tobacco companies in the United States. Data are reported on an annual basis. Four states (Florida, Minnesota, Mississippi, and Texas) provide the STATE System their Tobacco Settlement Revenue data independently.
Updated
May 30 2023
Views
4,718
2016-2019. This dataset is a de-identified summary table of prevalence rates for vision and eye health data indicators from the Medicaid Analytic eXtract (MAX) data. Medicaid MAX are a set of de-identified person-level data files with information on Medicaid eligibility, service utilization, diagnoses, and payments. The MAX data contain a convenience sample of claims processed by Medicaid and Children’s Health Insurance Program (CHIP) fee for service and managed care plans. Not all states are included in MAX in all years, and as of November 2019, 2014 data is the latest available. Prevalence estimates are stratified by all available combinations of age group, gender, and state. Detailed information on VEHSS Medicare analyses can be found on the VEHSS Medicaid MAX webpage (cdc.gov/visionhealth/vehss/data/claims/medicaid.html). Information on available Medicare claims data can be found on the ResDac website (www.resdac.org). The VEHSS Medicaid MAX dataset was last updated May 2023.
Updated
May 3 2023
Views
1,590
VEHSS Composite Prevalence Estimates
2017, 2019. This dataset contains estimates of the prevalence of vision loss and eye disorders generated using a Bayesian meta-analytic modeling approach that combines information from multiple, disparate data sources to produce comprehensive predictions of prevalence by age, race, gender, and geography at the national, state and county levels. These composite prevalence estimates are the primary surveillance measures developed by the Centers for Disease Control and Prevention’s Vision & Eye Health Surveillance System (VEHSS).
The vision loss prevalence estimates represent best-corrected visual acuity in the better-seeing eye. 'Any vision loss' represents any impairment or blindness of 20/40 or worse; 'US-defined blindness' refers to the subset of vision loss that is 20/200 or worse; 'Visual impairment' refers to the subset with visual acuity of 20/40 to <20/200.
The age-related macular degeneration (AMD) estimates represent AMD as measured with retinal imaging examination. ‘Vision threatening AMD’ includes patients with geographic atrophy, wet-form AMD, or choroidal neovascularization in either eye. ‘Non-vision threatening AMD’ includes patients with early or intermediate dry-form AMD defined as retinal pigment epithelium abnormalities or drusen ≥125 µm in the worse-affected eye, and do not have vision threatening AMD.
Data sources include the National Health and Nutrition Examination Survey (reference values), the American Community Survey, the National Survey of Children’s Health, Medicare Fee-For-Service claims, Medicaid claims, MarketScan commercial insurance claims, the Health Resources & Service Administration’s Area Resources File, and published examination study results from the Baltimore Pediatric Eye Disease Study, the Chinese American Eye Study, the Eye Diseases Prevalence Research Group, the Los Angeles Latino Eye Study, the Multi-Ethnic Study of Atherosclerosis Cohort and other studies.
For more information or to view this data in the VEHSS interactive data visualization application, visit https://www.cdc.gov/visionhealth/vehss/estimates/index.html.
2017, 2019. This dataset contains estimates of the prevalence of vision loss and eye disorders generated using a Bayesian meta-analytic modeling approach that combines information from multiple, disparate data sources to produce comprehensive predictions of prevalence by age, race, gender, and geography at the national, state and county levels. These composite prevalence estimates are the primary surveillance measures developed by the Centers for Disease Control and Prevention’s Vision & Eye Health Surveillance System (VEHSS).
The vision loss prevalence estimates represent best-corrected visual acuity in the better-seeing eye. 'Any vision loss' represents any impairment or blindness of 20/40 or worse; 'US-defined blindness' refers to the subset of vision loss that is 20/200 or worse; 'Visual impairment' refers to the subset with visual acuity of 20/40 to <20/200.
The age-related macular degeneration (AMD) estimates represent AMD as measured with retinal imaging examination. ‘Vision threatening AMD’ includes patients with geographic atrophy, wet-form AMD, or choroidal neovascularization in either eye. ‘Non-vision threatening AMD’ includes patients with early or intermediate dry-form AMD defined as retinal pigment epithelium abnormalities or drusen ≥125 µm in the worse-affected eye, and do not have vision threatening AMD.
Data sources include the National Health and Nutrition Examination Survey (reference values), the American Community Survey, the National Survey of Children’s Health, Medicare Fee-For-Service claims, Medicaid claims, MarketScan commercial insurance claims, the Health Resources & Service Administration’s Area Resources File, and published examination study results from the Baltimore Pediatric Eye Disease Study, the Chinese American Eye Study, the Eye Diseases Prevalence Research Group, the Los Angeles Latino Eye Study, the Multi-Ethnic Study of Atherosclerosis Cohort and other studies.
For more information or to view this data in the VEHSS interactive data visualization application, visit https://www.cdc.gov/visionhealth/vehss/estimates/index.html.
Updated
May 2 2023
Views
1,690
2014-2015. This dataset is a de-identified summary table of vision and eye health data indicators from Medicare, stratified by all available combinations of age group, race/ethnicity, gender, and state. Medicare claims for VEHSS includes beneficiaries who were fully enrolled in Medicare Part B Fee-for-Service (FFS) for the duration of the year. Medicare claims provide a convenience sample that includes approximately 30 million individuals annually, which represents nearly 89% of the US population aged 65 and older and 3.3% of the US population younger than 65, including persons disabled due to blindness. Medicare data for VEHSS include Service Utilization and Medical Diagnoses indicators. Data were suppressed for de-identification to ensure protection of patient privacy. Data will be updated as it becomes available. Detailed information on VEHSS Medicare analyses can be found on the VEHSS Medicare webpage (link). Information on available Medicare claims data can be found on the ResDac website (www.resdac.org). The VEHSS Medicare dataset was last updated in June 2018.
Updated
May 2 2023
Views
2,064
2017. This dataset contains estimates of the prevalence of visual acuity loss and visual acuity blindness in the United States in 2017. These estimates are created using a Bayesian meta-analytic modeling approach that combines information from multiple, disparate data sources to produce comprehensive predictions of prevalence by age, race, sex and geography. The vision loss prevalence estimates represent best-corrected visual acuity in the better-seeing eye. 'Any vision loss' represents any impairment or blindness of 20/40 or worse; 'US-defined blindness' refers to the subset of vision loss that is 20/200 or worse; 'Visual impairment' refers to the subset with visual acuity of 20/40 to <20/200.
Data sources include the National Health and Nutrition Examination Survey (reference values), the American Community Survey, the National Survey of Childrens Health, and published examination study results from the Baltimore Pediatric Eye Disease Study, the Chinese American Eye Study, the Eye Diseases Prevalence Research Group, the Los Angeles Latino Eye Study and the Multi-Ethnic Study of Atherosclerosis Cohort.
Updated
May 2 2023
Views
587
1995-2023. Centers for Disease Control and Prevention (CDC). State Tobacco Activities Tracking and Evaluation (STATE) System. E-Cigarette Legislation – Smokefree Indoor Air. The STATE System houses current and historical state-level legislative data on tobacco use prevention and control policies. Data are reported on a quarterly basis. Data include information related to state legislation on smokefree indoor air that apply to use of e-cigarettes in private worksites, restaurants, and bars.
Updated
May 1 2023
Views
1,846
1995-2023. Centers for Disease Control and Prevention (CDC). State Tobacco Activities Tracking and Evaluation (STATE) System. E-Cigarette Legislation – Preemption. The STATE System houses current and historical state-level legislative data on tobacco use prevention and control policies. Data are reported on a quarterly basis. Data include information related to summary state preemption of more stringent or differing local laws on smokefree indoor air, youth access and licensure that are applicable to e-cigarettes.
Updated
May 1 2023
Views
503
1995-2023. Centers for Disease Control and Prevention (CDC). State Tobacco Activities Tracking and Evaluation (STATE) System. E-Cigarette Legislation—Youth Access. The STATE System houses current and historical state-level legislative data on tobacco use prevention and control policies. Data are reported on a quarterly basis. Data include information related to restrictions, enforcement and penalties associated with the sale of e-cigarettes to youth through retail sales and vending machines.
Updated
May 1 2023
Views
1,217
1995-2023. Centers for Disease Control and Prevention (CDC). State Tobacco Activities Tracking and Evaluation (STATE) System. E-Cigarette Legislation—Youth Access. The STATE System houses current and historical state-level legislative data on tobacco use prevention and control policies. Data are reported on a quarterly basis. Data include information related to restrictions, enforcement and penalties associated with the sale of e-cigarettes to youth through retail sales and vending machines.
Updated
May 1 2023
Views
67,928
1995-2023. Centers for Disease Control and Prevention (CDC). State Tobacco Activities Tracking and Evaluation (STATE) System. E-Cigarette Legislation—Licensure. The STATE System houses current and historical state-level legislative data on tobacco use prevention and control policies. Data are reported on a quarterly basis. Data include information related to requirements, restrictions and penalties associated with holding a retail license to sell e-cigarettes over-the-counter and through vending machines.
Updated
May 1 2023
Views
4,344
1995-2023. Centers for Disease Control and Prevention (CDC). State Tobacco Activities Tracking and Evaluation (STATE) System. E-Cigarette Legislation—Licensure. The STATE System houses current and historical state-level legislative data on tobacco use prevention and control policies. Data are reported on a quarterly basis. Data include information related to requirements, restrictions and penalties associated with holding a retail license to sell e-cigarettes over-the-counter and through vending machines.
Updated
May 1 2023
Views
806
1995-2023. Centers for Disease Control and Prevention (CDC). State Tobacco Activities Tracking and Evaluation (STATE) System. Legislation—Licensure. The STATE System houses current and historical state-level legislative data on tobacco use prevention and control policies. Data are reported on a quarterly basis. Data include information related to requirements, restrictions and penalties associated with holding a retail license to sell tobacco products over-the-counter and through vending machines.
Updated
May 1 2023
Views
3,236
1995-2023. Centers for Disease Control and Prevention (CDC). State Tobacco Activities Tracking and Evaluation (STATE) System. Legislation—Licensure. The STATE System houses current and historical state-level legislative data on tobacco use prevention and control policies. Data are reported on a quarterly basis. Data include information related to requirements, restrictions and penalties associated with holding a retail license to sell tobacco products over-the-counter and through vending machines.
Updated
May 1 2023
Views
7,258
1995-2023. Centers for Disease Control and Prevention (CDC). State Tobacco Activities Tracking and Evaluation (STATE) System. Legislation—Licensure. The STATE System houses current and historical state-level legislative data on tobacco use prevention and control policies. Data are reported on a quarterly basis. Data include information related to requirements, restrictions and penalties associated with holding a retail license to sell tobacco products over-the-counter and through vending machines.
Updated
May 1 2023
Views
560
1995-2023. Centers for Disease Control and Prevention (CDC). State Tobacco Activities Tracking and Evaluation (STATE) System. Legislation – Fire-Safety. The STATE System houses current and historical state-level legislative data on tobacco use prevention and control policies. Data are reported on a quarterly basis. Data include fire-safe cigarette restrictions, enforcement, and penalties.
Updated
May 1 2023
Views
4,024
2015-2020. The data in this filtered view come from the BRFSS data set.
Updated
May 1 2023
Views
1,882
2015-2020. The data in this filtered view come from the BRFSS data set.
Updated
May 1 2023
Views
4,188
2015-2021. This data set contains data from BRFSS.
Updated
May 1 2023
Views
24,438
2008-2023. American Lung Association. Cessation Coverage. Medicaid data compiled by the Centers for Disease Control and Prevention’s Office on Smoking and Health were obtained from the State Tobacco Cessation Coverage Database, developed and administered by the American Lung Association. Data from 2008-2012 are reported on an annual basis; beginning in 2013 data are reported on a quarterly basis. Data include state-level information on Medicaid coverage of approved medications by the Food and Drug Administration (FDA) for tobacco cessation treatment; types of counseling recommended by the Public Health Service (PHS) and barriers to accessing cessation treatment. Note: Section 2502 of the Patient Protection and Affordable Care Act requires all state Medicaid programs to cover all FDA-approved tobacco cessation medications as of January 1, 2014. However, states are currently in the process of modifying their coverage to come into compliance with this requirement. Data in the STATE System on Medicaid coverage of tobacco cessation medications reflect evidence of coverage that is found in documentable sources, and may not yet reflect medications covered under this requirement.
Updated
April 27 2023
Views
1,452
2008-2023. American Lung Association. Cessation Coverage – Medicaid Barriers to Treatments. Medicaid data compiled by the Centers for Disease Control and Prevention’s Office on Smoking and Health were obtained from the State Tobacco Cessation Coverage Database, developed and administered by the American Lung Association. Data from 2008-2012 are reported on an annual basis; beginning in 2013 data are reported on a quarterly basis. Data include state-level information on Medicaid policies that make it hard for tobacco users to access cessation treatment and discourage them from quitting. Medicaid barriers include: co-payments, prior authorization, counseling required for medications, stepped care therapy, limits on duration, annual limits, lifetime limits and other barriers such as dollar limits, limits on the number of monthly prescriptions, no provision for refills or limits on which type of provider can perform treatment.
Updated
April 27 2023
Views
28,728
2008-2023. American Lung Association. Cessation Coverage – Medicaid Coverage of Cessation Treatments. Medicaid data compiled by the Centers for Disease Control and Prevention’s Office on Smoking and Health were obtained from the State Tobacco Cessation Coverage Database, developed and administered by the American Lung Association. Data from 2008-2012 are reported on an annual basis; beginning in 2013 data are reported on a quarterly basis. Data include state-level information on Medicaid coverage of approved medications by the Food and Drug Administration (FDA) for tobacco cessation treatment and the types of counseling recommended by the Public Health Service (PHS). Approved medications by the FDA include: Nicotine patch, Nicotine gum, Nicotine lozenge, Nicotine nasal spray, Nicotine inhaler, Bupropion (Zyban) and Varenicline (Chantix). The types of counseling recommended by the PHS are: individual counseling, group counseling and phone counseling. Data do not include phone counseling which is available in every state through quitlines.
Updated
April 27 2023
Views
2,804
2008-2023. American Lung Association. Cessation Coverage – Medicaid Coverage of Treatments – Medications. Medicaid data compiled by the Centers for Disease Control and Prevention’s Office on Smoking and Health were obtained from the State Tobacco Cessation Coverage Database, developed and administered by the American Lung Association. Data from 2008-2012 are reported on an annual basis; beginning in 2013 data are reported on a quarterly basis. Data include state-level information on Medicaid coverage of approved medications by the Food and Drug Administration (FDA) for tobacco cessation treatment. Approved medications by the FDA include: Nicotine patch, Nicotine gum, Nicotine lozenge, Nicotine nasal spray, Nicotine inhaler, Bupropion (Zyban) and Varenicline (Chantix).
Updated
April 27 2023
Views
2,419
2008-2023. American Lung Association. Cessation Coverage – Medicaid Coverage of Treatments – Counseling. Medicaid data compiled by the Centers for Disease Control and Prevention’s Office on Smoking and Health were obtained from the State Tobacco Cessation Coverage Database, developed and administered by the American Lung Association. Data from 2008-2012 are reported on an annual basis; beginning in 2013 data are reported on a quarterly basis. Data include state-level information on types of counseling recommended by the Public Health Service (PHS). The types of counseling recommended by the PHS are: individual counseling, group counseling and phone counseling. Data do not include phone counseling which is available in every state through quitlines.
Updated
April 27 2023
Views
2,223
2008-2023. American Lung Association. Cessation Coverage – Medicaid Coverage of Cessation Treatments. Medicaid data compiled by the Centers for Disease Control and Prevention’s Office on Smoking and Health were obtained from the State Tobacco Cessation Coverage Database, developed and administered by the American Lung Association. Data from 2008-2012 are reported on an annual basis; beginning in 2013 data are reported on a quarterly basis. Data include state-level information on Medicaid coverage of approved medications by the Food and Drug Administration (FDA) for tobacco cessation treatment and the types of counseling recommended by the Public Health Service (PHS). Approved medications by the FDA include: Nicotine patch, Nicotine gum, Nicotine lozenge, Nicotine nasal spray, Nicotine inhaler, Bupropion (Zyban) and Varenicline (Chantix). The types of counseling recommended by the PHS are: individual counseling, group counseling and phone counseling. Data do not include phone counseling which is available in every state through quitlines.
Updated
April 27 2023
Views
1,894
2008-2023. American Lung Association. Cessation Coverage. Medicaid data compiled by the Centers for Disease Control and Prevention’s Office on Smoking and Health were obtained from the State Tobacco Cessation Coverage Database, developed and administered by the American Lung Association. Data from 2008-2012 are reported on an annual basis; beginning in 2013 data are reported on a quarterly basis. Data include state-level information on Medicaid coverage of approved medications by the Food and Drug Administration (FDA) for tobacco cessation treatment; types of counseling recommended by the Public Health Service (PHS) and barriers to accessing cessation treatment. Note: Section 2502 of the Patient Protection and Affordable Care Act requires all state Medicaid programs to cover all FDA-approved tobacco cessation medications as of January 1, 2014. However, states are currently in the process of modifying their coverage to come into compliance with this requirement. Data in the STATE System on Medicaid coverage of tobacco cessation medications reflect evidence of coverage that is found in documentable sources, and may not yet reflect medications covered under this requirement.
Updated
April 27 2023
Views
7,573
Tags
A-Z
- ... (29)
- 500 cities (35)
- 500cities (11)
- aad (327)
- aaf (327)
- abuse (21)
- access to care (6)
- acs (2)
- activity (1)
- administration and management (6)
- adolescents (1)
- adult (12)
- adult cigarette use (1)
- adults (7)
- age (6)
- age-adjusted (2)
- aging (3)
- alcohol (349)
- alcohol use (21)
- alcohol-related disease impact (327)
- allocation (1)
- american community survey (1)
- american lung association (6)
- any tobacco (2)
- appropriation (1)
- appropriations (1)
- art (4)
- arthritis (20)
- assisted reproductive technology (4)
- astdd (1)
- asthma (19)
- average cost per pack (1)
- awards (1)
- barriers to treatment (1)
- bars (1)
- basic screening survey (1)
- behavioral (40)
- behaviors (36)
- best practices (4)
- best practices for comprehensive tobacco control programs (5)
- bike (1)
- binge (1)
- blind (4)
- blindness (2)
- blood pressure (6)
- body mass index (bmi) (1)
- boundaries (2)
- breastfed (1)
- breastfeeding (23)
- brfss (62)
- bss (1)
- built environment (1)
- callers (6)
- cancer (21)
- cardiovascular (12)
- cardiovascular disease (49)
- cardiovascular health (6)
- caregiver (3)
- caries (1)
- caries experience (1)
- casinos (1)
- cataract (1)
- cdc (3)
- cdi (19)
- census (41)
- census tract (7)
- census tracts (1)
- centers for disease control and prevention (2)
- cerebrovascular disease (8)
- cessation (12)
- cessation coverage (7)
- cessation intervention (5)
- chd (1)
- checkup (1)
- child (2)
- children (2)
- cholesterol (8)
- chronic disease indicators (19)
- chronic kidney disease (19)
- chronic obstructive pulmonary disease (19)
- cigar (5)
- cigar use (1)
- cigarette (11)
- cigarette excise tax (1)
- cigarette sales (2)
- cigarette use (7)
- cities (11)
- city (8)
- claims (4)
- claims data (2)
- cleft lip/cleft palate recording (6)
- cleft lip/cleft palate referral to care (6)
- clinic (4)
- cognitive health (3)
- colorectal (1)
- combustibles (2)
- comprehensive medicaid coverage (2)
- comprehensive medicaid coverage of cessation treatment (2)
- comprehensive smokefree indoor air (1)
- consumption (1)
- contact lenses (5)
- contraception (21)
- copd (1)
- coronary (1)
- coronary heart disease (7)
- counseling (1)
- counties (9)
- county (25)
- current (9)
- current asthma (1)
- cvd risk factors (6)
- demographics (6)
- dental (1)
- dental care (5)
- dental cleaning (6)
- dental sealants (1)
- dental visits (6)
- dentist (4)
- department of health and human services (1)
- diabetes (31)
- diagnosed prevalence (2)
- disability (19)
- diseases of the heart (3)
- division of oral health (10)
- dnpao (6)
- dollars (1)
- drinking (1)
- e-cigarette (13)
- ecigarette (3)
- education (6)
- estimates (31)
- ethnicity (6)
- ever (4)
- every day (3)
- expenditure (1)
- expenditures (1)
- eye diseases (10)
- eye exams (3)
- fact sheet (12)
- factor (31)
- falls (3)
- faq (6)
- farm (1)
- federal (1)
- fee-for-service plan (1)
- fertility (4)
- fire safety (1)
- former (3)
- frequency (3)
- frequent (2)
- fruit (3)
- fruits and vegetables (4)
- funding (3)
- funds (1)
- gaming (1)
- gats (1)
- gender (6)
- ghpss (1)
- gis (19)
- glasses (5)
- glaucoma (1)
- global (5)
- glossary (17)
- grants (1)
- gross cigarette tax revenue per state (1)
- group counseling (1)
- gshs (4)
- gsps (1)
- gtss (4)
- gyts (1)
- health (17)
- health communication (1)
- health communication interventions (5)
- healthy people (4)
- healthy people 2020 (1)
- heart (7)
- heart disease (12)
- heart diseases (10)
- high school (9)
- homes (1)
- hookah (2)
- hospitalizations (1)
- housing (1)
- hypertension (18)
- immunization (19)
- individual counseling (1)
- infant health (21)
- infants (1)
- infertility (4)
- infographic (6)
- infrastructure (6)
- insurance (1)
- interactive map (9)
- intervention (6)
- interventions (1)
- kidney (1)
- leading health indicator (1)
- legislation (33)
- licensure (5)
- loose tobacco (2)
- low income (1)
- mammogram (1)
- mammography (1)
- managed care plan (3)
- marketscan (1)
- max (1)
- medicaid (22)
- medicaid barriers to treatment (1)
- medicaid coverage of cessation treatment (6)
- medical diagnoses (4)
- medicare (1)
- medication (1)
- mental (1)
- mental health (40)
- methodology (16)
- methods (1)
- middle school (7)
- mmsa (2)
- money (1)
- morbidity (21)
- mortality (3)
- multiunit housing (1)
- myocardial infarction (1)
- national (2)
- national immunization survey (1)
- national quitline data warehouse (6)
- never (3)
- nhanes (1)
- nhis (1)
- nis (1)
- nohss (10)
- non-combustibles (2)
- nqdw (6)
- nsch (2)
- nutrition (4)
- nutrition physical activity and weight status (19)
- nyts (1)
- obese (1)
- obesity (29)
- office on smoking and health (36)
- older adults (19)
- oral health (35)
- osh (85)
- oshdata (3)
- outcomes (36)
- overall health (3)
- overarching conditions (19)
- overweight (3)
- pap (1)
- papanicolaou (1)
- per capita (3)
- physical (2)
- physical activity (15)
- physical activity education (1)
- pipe (3)
- pipe tobacco (2)
- place (6)
- places (25)
- policy (40)
- preconception health (21)
- preemption (8)
- pregnancy history (21)
- prenatal care (21)
- prevalence (82)
- prevention (38)
- products (2)
- programs (6)
- public health (19)
- qit (1)
- questions (2)
- quit (11)
- quit attempt (1)
- quit-now (6)
- quitline (8)
- race (6)
- recommendation (1)
- recommended level (1)
- reproductive health (40)
- restaurants (1)
- risk (56)
- risk behavior (16)
- risk factors (2)
- roll-your-own tobacco (2)
- rules (1)
- sae (2)
- sam (2)
- sammec (4)
- school based sealant programs (6)
- school personnel (1)
- screening (3)
- screenings (3)
- secondhand smoke (4)
- service utilization (6)
- services (12)
- sexual contacts (7)
- sexual identity (7)
- sexual orientation (7)
- shapefile (2)
- sleep (1)
- sleep behavior (21)
- slides (4)
- smart (4)
- smoke exposure (21)
- smokefree (5)
- smokefree campus (2)
- smokefree indoor air (8)
- smokeless (7)
- smokeless tobacco products (1)
- smoker (9)
- smoking (21)
- smoking status (7)
- soda (1)
- sodium (6)
- some days (3)
- spending (1)
- state (10)
- state and community (1)
- state and community interventions (5)
- state dental directors (6)
- state oral health program characteristics (6)
- state system (58)
- status (18)
- stress (21)
- stroke (28)
- student health (4)
- students (1)
- success rates (4)
- surveillance (15)
- surveillance and evaluation (6)
- survey (61)
- survey questions (1)
- system (2)
- tax (8)
- tax burden on tobacco (2)
- tobacco (78)
- tobacco consumption (2)
- tobacco products (2)
- tobacco settlement payments (1)
- tobacco use (32)
- tooth decay (1)
- tooth loss (6)
- total recommended program costs (2)
- tract (6)
- tracts (35)
- transportation (1)
- treated prevalence (1)
- truven (1)
- tv (1)
- unhealthy (20)
- unintended pregnancy (21)
- untreated tooth decay (1)
- user (2)
- vaccines (3)
- vegetable (1)
- vegetables (2)
- vhi (10)
- vision (2)
- vision correction (1)
- vision exam measures (1)
- vision impairment (12)
- visual (2)
- visual acuity (1)
- visual function (6)
- vsp (1)
- walk (1)
- walking (1)
- water fluoridation (4)
- wfrs (4)
- wic (22)
- wic-pc (1)
- work (1)
- workforce (6)
- worksites (1)
- youth (5)
- youth access (3)
- youth cigarette use (1)
- youth online (16)
- youth tobacco sales (1)
- ypll (327)
- yrbs (12)
- yrbss (3)
- zcta (6)
- zip code (6)
- zoning (1)